Cargando…
Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia
Acute myeloid leukemia (AML) is an invasive hematopoietic malignancy caused by excessive proliferation of myeloblasts. Classical chemotherapies and cell transplantation therapies have remarkable efficacy in AML treatment; however, 30–40% of patients relapsed or had refractory disease. The resistance...
Autores principales: | Jia, Yimin, Sun, Cun, Chen, Ting, Zhu, Hui, Wang, Tianrui, Ye, Yan, Luo, Xing, Zeng, Xiaoqiang, Yang, Yun, Zeng, Hao, Zou, Quanming, Liu, Enqiang, Li, Jieping, Sun, Hongwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369765/ https://www.ncbi.nlm.nih.gov/pubmed/37491290 http://dx.doi.org/10.1186/s12951-023-01968-2 |
Ejemplares similares
-
Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape
por: Luo, Xing, et al.
Publicado: (2022) -
Targeting Approaches of Nanomedicines in Acute Myeloid
Leukemia
por: Huang, Xiao, et al.
Publicado: (2019) -
Recent progress in nanomedicine-mediated cytosolic delivery
por: Son, Hangyu, et al.
Publicado: (2023) -
Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs
por: Sun, Hongwu, et al.
Publicado: (2012) -
Cancer nanomedicine: a review of recent success in drug delivery
por: Tran, Stephanie, et al.
Publicado: (2017)